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ABSTRACT:SunSisanovelS-glycosyltransferaseinvolved
inthe biosynthesis of the antimicrobial peptidesublancin. It
selectively modiﬁes Cys22 in a 56 amino acid peptide
substrate SunA and can accept a variety of NDP sugars.
Thisstudyreportsthesubstrateselectivitywithregardtothe
peptide substrate and the antimicrobial activity of the
resulting sublancinanalogues.The resultssuggest that SunS
recognizes an α-helix N-terminal of the Cys to be glycosy-
lated,whichispresentinaﬂexiblelinker.Interestingly,when
Cys22 is mutated, sugar attachment is not required for
sublancin antimicrobial activity. Furthermore, the sublan-
cin-producing strain Bacillus subtilis 168 also becomes
susceptible to such mutants. These data suggest that S-gly-
cosylation may be important for self-resistance.
N
-LinkedandO-linkedglycosylationofproteinsarecommon
post-translational modiﬁcations.
14 Examples of S-linked
glycopeptides are rare
510 and until recently have not been well
characterized.Inthepastyear,twoexamplesofbacterialS-linked
glycopeptides that display antimicrobial activities were reported:
sublancin produced by Bacillus subtilis 168 and glycocin F
produced by Lactobacillus plantarum KW30.
11,12 The novel S-
glycosyltransferaseSunSwasdemonstratedtoglucosylateCys22
during the biosynthesis of sublancin (Figure 1). Its enzymatic
activity was reconstituted in vitro, and investigation of its sub-
stratespeciﬁcityshowedthatSunScanacceptavarietyofnucleo-
tide sugars as sugar donors.
11 In this study, we explored the
peptide substrate speciﬁcity of SunS and its potential application
in generating sublancin analogues. These studies suggest that
SunS recognizes an α-helical segment of its substrate and then
glycosylates cysteine residues in a ﬂexible loop following this
helix. Interestingly, when Cys22 in sublancin was mutated to Ser
or Ala, the nonglycosylated mutant retained antimicrobial activ-
ity against sublancin-sensitive strains and also gained activity
against the producer organism. These ﬁndings, combined with
thepreviousobservationthatthetypeofsugarattachedtoCys22
is not important for bioactivity,
11 suggest that glycosylation at
Cys22 may constitute an unusual type of self-resistance.
Undertheconditionsoftheinvitroassays,allﬁveCysresidues
in the SunA substrate peptide are reduced and available for
glycosylation, yet only Cys22 is modiﬁed. As noted previously,
11
the four Cys residues in SunA that are not glycosylated by SunS
are ﬂanked by Gln, Ala, Arg, and Phe, whereas Cys22 that is gly-
cosylated is ﬂanked by two Gly amino acids (Figure 1). There-
fore, the importance of the ﬂanking residues of Cys22 for the
regioselectivitydisplayed by SunS was ﬁrst investigated. The two
glycine residues ﬂanking Cys22 were mutated to Ala, Lys, Glu,
and Phe (Table 1). Interestingly, all of these SunA mutants were
accepted as substrates by SunS in the presence of uridine
diphosphate glucose (UDP-glucose), as demonstrated by MAL-
DI-TOF-MS (Figure S1 in the Supporting Information), and all
were glucosylated on Cys22. Therefore, the ﬂanking residues do
not provide the basis for the observed regiochemistry. However,
the ﬂanking residues do impact the eﬃciency of catalysis, as
demonstrated by the time dependence of substrate conversion
monitoredbyHPLC.Ataﬁnalconcentrationof25μM,wildtype
(wt)SunA,SunA-G23A,andSunA-G23Fwerefullyconvertedto
their glycopeptide products in 15 min in the presence of 150 nM
SunS. Under the same conditions, conversion of SunA-G23E
took 3h,whereasmodiﬁcationofSunA-G23Kwasnotobserved.
However, SunA-G23K was glucosylated when a longer incuba-
tion time and higher enzyme concentration (5 μM) were used
(FigureS1g).Theseresultsindicatethatachargedﬂankingresidue
of Cys22 slows down glycosylation. The size of the ﬂanking resi-
dues appears to be less important than their charge state.
Toinvestigate whether theselectivityforCys22isbasedonits
positionwithintheSunApeptide,twomutantpeptideswerepro-
ducedtoinvestigatetheeﬀectofa“changeinregister”(Table1).
Figure 1. Post-translational modiﬁcations during sublancin biosynth-
esis. The leader peptide of the SunA precursor peptide is shown in red,
and the double-glycine-type proteolytic cleavage site is underlined. The
predicted helix-forming regions are underlined with blue bars. The
cysteine residues that are not glycosylated are shown in green, and the
glycosylated residue Cys22 is shown in red. The order of glycosylation
anddisulﬁde-bondformationinvivoisunknownandisarbitrarilyshown
with glycosylation occurring ﬁrst. Residue numbering is based on the
core peptide of SunA.
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In one peptide, SunA-Xa-ΔI20, Ile20 was deleted, bringing
Cys22oneresidueclosertotheN-terminus.Inasecondpeptide,
SunA-Xa-(S16-G17insAAA), three Ala residues were inserted
between Ser16 and Gly17 to position the Cys three residues
further away from the N-terminus. In both SunA mutant pep-
tides, a Factor Xa cleavage site was engineered to allow removal
of the leader peptide and evaluation of the bioactivities of the
sublancin analogues. Incubation of these substrate analogues
with SunS resulted in glucosylation of both peptides at the third
Cys residue from the N-terminus (equivalent to Cys22 in wt
SunA), as determined by ESI-MSMS. Thus, SunS tolerates
changes in the position of the targeted Cys residue toward either
theN-orC-terminuswithoutcompromisingitsregio-andchem-
oselectivity (Figure S2).
TheobservationthatSunScanselectivelymodifyCysresidues
at positions other than the 22nd amino acid of the core pep-
tide encouraged exploration of its capability to conjugate multi-
ple sugar moieties. First, the mutant peptide SunA-Xa-T19C
was produced to introduce an additional Cys in the stretch of
amino acids between Cys14 and Cys29 that encompasses Cys22
(Table 1). After incubation with SunS, only a monoglycosylated
peptide was observed by MALDI-TOF-MS. However, ESI-
MSMS analysis revealed that the glucose was present on either
Cys19orCys22(FigureS3).TheseresultsindicatethatSunScan
modifyCysresiduesateitherpositionbutnotboth.Althoughthe
MSMS data could not quantify the selectivity of SunS for Cys19
or Cys22 in this mutant, the intensities of the fragment ions
showed that the enzyme does not display a strong preference for
either.
Interestingly,incubationofSunSwithaSunAmutantinwhich
the ﬂanking residues of Cys14 (one of the residues not modiﬁed
in wt SunA) were mutated to glycines (SunA-Xa-Q13G-A15G,
Table 1) resulted in a mixture of mono- and bisglycosylated
products (Figure S4a). Subsequent ESI-MSMS analysis showed
that both the Cys14 and Cys22 residues were modiﬁed (Figure
S4b,c). The observation that SunS can modify two Cys residues
in SunA-Xa-Q13G-A15G but not in SunA-Xa-T19C indicates
that a minimal distance between two Cys residues is required
in order to accommodate the initially formed monoglycosy-
lated peptide into the active site for a subsequent second glyco-
sylation.
Whereas it is clear that SunS has substantial tolerance toward
mutations in its peptide substrate, the basis of its substrate
recognition mechanism is still largely unknown. Previous studies
showed that the leader peptide of SunA is not required for
enzymatic processing by SunS in vitro.
11 Therefore, the core
peptide must provide suﬃcient binding aﬃnity for substrate re-
cognitionandprocessing.Giventheoutcomeofourmutagenesis
studies, we wondered whether perhaps secondary structure ele-
ments in SunA would be recognized by SunS. Structure predic-
tion tools (PSIPRED
14) anticipated two α-helical regions in the
reduced core peptide spanning residues 315 and 2636
(Figure1).Circulardichroismexperimentssupporttheexistence
of α-helical character in both reduced (no disulﬁdes) and native
sublancinandinthereduced,linearHis6-SunApeptide(datanot
shown). In addition, the recently solved NMR structure of the
S-linked glycopeptide bacteriocin glycocin F, which shares
structural similarity with sublancin (Figure S5), consists of two
α-helices held together by a pair of disulﬁde bonds.
15 The two
α-helices in glycocin F project well onto regions 714 and 29
36ofSunA,althoughthetwopeptideshavenosequenceidentity
except for the four cysteines (Figure S5). If such a helical struc-
ture provides the basis for enzymesubstrate recognition, it
oﬀers a possible explanation for the observed regioselectivity of
SunS. The four Cys residues in SunA that are not modiﬁed by
SunS are all inside the proposed helical regions, whereas the Cys
thatismodiﬁed(Cys22)isinaﬂexiblecoilregionconnectingthe
helices. Thishypothesisissupported bythedoubleglycosylation
observed in SunA-Xa-Q13G-A15G. The PSIPRED structure
prediction program
14 suggests that because of the helix-breaking
residues Gly13 and Gly15, Cys14 is no longer within the N-
terminal α-helix in this mutant, possibly explaining why Cys14
was glucosylated by SunS.
To investigate further the importance of each of the two
proposedhelicesinthecore peptide ofSunAforsubstraterecog-
nition by SunS, two peptides spanning residues 127 (SunA-
1-27)and1626(SunA-16-26)weresynthesizedbysolid-phase
peptide synthesis (Table S2). A third peptide, SunA-17-37, was
obtained by expression of SunA-S16E in Escherichia coli, diges-
tion of the peptide with endoproteinase GluC, and HPLC puri-
ﬁcation. Incubation of these three peptides with SunS under the
standard assay conditions resulted in glycosylated SunA-1-27,
whereas SunA-16-26 and SunA-17-37 were not recognized as
substrates. These results suggest that the presence of the N-
terminal helical region (residues 315) of the core peptide is
required for substrate recognition whereas the C-terminal helix
(residues 2636) is dispensable and the ﬂexible linker connect-
ing the helices (residues 1626) is not suﬃcient. As a further
test of the hypothesis that the N-terminal helix in the core
peptide of SunS is important for substrate recognition, the helix-
breaking residue Pro was introduced at position 11 of SunA by
site-directed mutagenesis. The peptide fragments SunA-(5-33)-
W11P and SunA-(5-33) were then generated by trypsin diges-
tion of SunA-W11P and wt SunA, respectively (Table S2).
Incubation of these peptides with SunS showed that the
proline mutant SunA-(5-33)-W11P peptide was not a sub-
strate whereas SunA-(5-33)was stillglycosylated (Figure S6).
Therefore, the N-terminal helix appears to be essential for
substrate recognition by SunS.
Table1. PartialSequencesofSunAPeptides(Residues1130)
a
aMutations are highlighted in yellow. Cysteines that were glucosylated
by SunS are shown in red underlined font.16396 dx.doi.org/10.1021/ja2075168 |J. Am. Chem. Soc. 2011, 133, 16394–16397
Journal of the American Chemical Society COMMUNICATION
The relaxed substrate speciﬁcity of SunS observed herein also
provided a convenient tool for generating a series of sublancin
analogues. The leader peptides were removed from glucosylated
SunA-Xa-G23E, SunA-Xa-G23F, SunA-Xa-ΔI20, and SunA-
Xa-(S16-G17insAAA) usingFactorXa.Subsequently,thesepep-
tides were subjected to the previously reported oxidative folding
procedure to facilitate the formation of the correct disulﬁdes.
11
Interestingly, all of the reconstituted sublancin analogues exhib-
ited similar growth inhibitory activity against B. subtilis 6633 as
reconstitutedwtsublancin(Figure2),suggestingthatneitherthe
residuesﬂanking theglucosylatedCysnortheprecise position of
glucose attachment are critical for its antimicrobial potency.
In our previous study, we reported that glycosylation of SunA
is essential for antimicrobial activity of sublancin.
11 Further in-
vestigation revealed that without glycosylation, the correct disul-
ﬁde bonds of sublancin are not formed during the oxidative fold-
ingprocess(FigureS7).Presumably,thefreethiolofunmodiﬁed
Cys22 disrupts the formation of the correct disulﬁde bridges by
thioldisulﬁde exchange.
16 Hence, the importance of the actual
glycosylation for antimicrobial activity has not been tested. To
provide additional information regarding this question, the mu-
tants SunA-Xa-C22S and SunA-Xa-C22A were generated. Sur-
prisingly, after proteolytic removal of the leader peptide and
subsequent oxidative folding, both sublancin-C22S and sublan-
cin-C22A exhibited similar growth inhibitory activity against B.
subtilis6633asreconstitutedwtsublancin(Figure3B).Similarto
the observationsforsublancin,removal of theleader peptidewas
required for the bioactivity of both sublancin analogues. These
results indicate that the presence of sugar moieties at position 22
is not required for the antimicrobial activity of sublancin. The
observation that the glucose is not important for bioactivity
also explains why sublancin analogues with a variety of diﬀerent
sugars attached to Cys22 all exhibit similar antimicrobial acti-
vity
11 and why analogues with the glucosylated Cys at diﬀerent
positions in the loop connecting the two α-helices are also all
active (Figure 2). It therefore appears that the two helices held
together bythe disulﬁde bonds are most important for biological
activity. To rule out the possibility that the sublancin C22S
mutant acts by a diﬀerent mechanism of action, we tested the
compound against a B. subtilis 6633 mutant strain that acquired
resistance upon exposure to wt sublancin. Neither wt sublancin nor
theC22Smutantdisplayedantimicrobialactivityagainstthismutant
strain at concentrations of up to 50 μM, suggesting that the C22S
mutant acts by the same mechanism of action as wt sublancin.
We also tested the activity of sublancin-C22S against the
sublancin producing strain B. subtilis 168. As expected, neither
authentic nor reconstituted sublancin showed inhibitory activity
against B. subtilis 168 (Figure 3C), presumably because of the
self-resistance mechanisms in the producer organism mediated
bySunI.
17Surprisingly,however,B.subtilis168wassusceptibleto
sublancin-C22S (Figure 3C), suggesting the possibility that
glycosylation is related to a self-resistance mechanism, possibly
in combination with SunI. Future studies will focus on further
evaluation of this possibility.
In summary, we have demonstrated that a novel S-linked
glycosyl transferase, SunS, exhibits high promiscuity in regard to
its peptide substrates without losing its chemo- and regioselectivity.
The data presented here suggest that the enzyme recognizes an
α-helix that spans approximately residues 315. A variety of
sublancin analogues were generated by utilizing SunS to modify
mutant substrates. These mutants show that glucose attachment
is not required for the antimicrobial activity of sublancin.
Figure 2. Antimicrobial assays of sublancin analogues against B. subtilis
6633. (1) sublancin analogue G23E; (2) sublancin analogue G23F; (3)
sublancin analogue S16G17insAAA; (4) sublancin analogue ΔI20; (5)
reconstitutedwtsublancin;(6)oxidativefoldingbuﬀer(50mMTris,pH
7.5, 2 mM oxidized glutathione, 2 mM reduced glutathione, 0.1 mM
EDTA). All of the peptides were reconstituted from their precursor
peptides.
Figure 3. Bioactivity assays of sublancin analogues C22S and C22A.
(A) Structures of sublancin analogues C22S and C22A. (B) Agar-well
diﬀusion assay of sublancin and sublancin analogues C22S and C22A
against B. subtilis 6633: (1) negative control; (2) SunA-Xa after
glucosylation and oxidative folding; (3) SunA-Xa after oxidative folding
and proteolytic removal of the leader peptide; (4) SunA-Xa after
glucosylation, proteolytic removal of the leader peptide, and oxidative
folding (reconstituted sublancin); (5) SunA-Xa C22S after proteolytic
removal of the leader peptide and oxidative folding; (6) product of
SunA-Xa-C22S after oxidative folding; (7) SunA-Xa C22A after proteo-
lytic removal of the leader peptide and oxidative folding; (8) SunA-Xa-
C22A after oxidative folding. (C) Activities of reconstituted sublancin
and its analogue C22S (35 μM) against B. subtilis 168.16397 dx.doi.org/10.1021/ja2075168 |J. Am. Chem. Soc. 2011, 133, 16394–16397
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